Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Riboflavin topical - Avedro

Next Previous
Drug Profile

Riboflavin topical - Avedro

Alternative Names: Epi-on; Epioxa™; iLink™; KXL; KXL System®; ParaCel; Paracel 1; Paracel 2 R0185; Photrexa; Photrexa Viscous; Riboflavin 5’-phosphate in 20% dextran ophthalmic solution; Riboflavin 5’-phosphate ophthalmic solution; Riboflavin ophthalmic solution; Riboflavin ophthalmic solution/KXL system; VibeX; VibeX Rapid; VibeX Xtra

Latest Information Update: 05 Mar 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Avedro
  • Class Antimigraines; Eye disorder therapies; Flavins; Small molecules; Vitamins
  • Mechanism of Action Photosensitisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Corneal injuries; Keratoconus
  • New Molecular Entity No

Highest Development Phases

  • Marketed Corneal injuries; Keratoconus

Most Recent Events

  • 24 Feb 2025 US FDA accepts NDA for Riboflavin topical for Keratoconus for review
  • 24 Feb 2025 US FDA assigns PDUFA action date of (20/10/2025) for Riboflavin topical for Keratoconus
  • 23 Dec 2024 Glaukos Corporation submites New Drug Application (NDA) to US FDA for Keratoconus

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top